Research Comparison
Semaglutide vs Tirzepatide
A side-by-side research comparison of Semaglutide and Tirzepatide drawn from DRPSHP' peptide database records.
Semaglutide
Semaglutide is best understood as human GLP-1 re-engineered so that it lasts. The native hormone is a 31-residue peptide destroyed in the bloodstream within a couple of minutes; semaglutide keeps the 31-residue frame but swaps in three changes, referenced to native numbering. Position 8 carries aminoisobutyric acid (Aib) so that dipeptidyl peptidase-4 cannot clip it, position 34 holds arginine instead of lysine, and the lysine at position 26 bears an 18-carbon diacid chain on a short spacer that lets the molecule ride on albumin. Receptor pharmacology, rodent models and a very extensive human trial record in metabolic disease all exist. A live question is how an albumin-bound molecule of this size reaches the brain regions where the receptor sits.
Tirzepatide
Two incretin receptors, one for GIP and one for GLP-1, are both switched on by tirzepatide, a synthetic 39-residue peptide. Its sequence is built mainly on GIP, carries aminoisobutyric acid at positions 2 and 13, and finishes with a tail that resembles exendin-4. Circulation time is extended by a 20-carbon fatty diacid joined to a lysine through a linker, which lets the molecule bind albumin. The compound has been examined in receptor pharmacology, rodent work and an extensive set of human clinical studies in metabolic disease. A continuing debate concerns the GIP half of the design, partly because rodent experiments have produced overlapping outcomes from both stimulating and blocking the GIP receptor.
Reading a comparison
A comparison places two records side by side; it does not merge them. Each description above is drawn from that compound's own record, and the two were not necessarily characterised by the same methods, at the same time, or to the same level of detail. Before comparing any attribute, it is worth establishing that both records describe the substance you think they describe — names are not identifiers, and two entries sharing a name can differ in salt form, stereochemistry or the convention used to state a mass. Where a figure carries no method beside it, the comparison is between two reported numbers rather than between two measurements.